| SC 13G/A | 2023-02-08 | Redmile Group, LLC | Old Ayala, Inc | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-07 | Harel Insurance Investments & Financial Services Ltd. | Old Ayala, Inc | 403,523 | 8.3% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Old Ayala, Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-01-23 | Schindel Yair Chaim | Old Ayala, Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-01-09 | Schindel Yair Chaim | Ayala Pharmaceuticals, Inc. | 2,991,473 | 20.2% | EDGAR |
| SC 13G/A | 2022-10-31 | Novartis Institutes for BioMedical Research, Inc. | Ayala Pharmaceuticals, Inc. | 698,777 | 4.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Redmile Group, LLC | Ayala Pharmaceuticals, Inc. | 1,472,522 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Ayala Pharmaceuticals, Inc. | 710,235 | 5.1% | EDGAR |
| SC 13G/A | 2022-01-31 | Harel Insurance Investments & Financial Services Ltd. | Ayala Pharmaceuticals, Inc. | 2,153,272 | 15.5% | EDGAR |
| SC 13G/A | 2022-01-24 | Schindel Yair Chaim | Ayala Pharmaceuticals, Inc. | 2,991,473 | 21.5% | EDGAR |
| SC 13G/A | 2021-03-02 | Redmile Group, LLC | Ayala Pharmaceuticals, Inc. | 1,381,077 | 10.0% | EDGAR |
| SC 13G | 2021-02-16 | Redmile Group, LLC | Ayala Pharmaceuticals, Inc. | 667,816 | 5.2% | EDGAR |
| SC 13G | 2021-02-08 | Schindel Yair Chaim | Ayala Pharmaceuticals, Inc. | 2,991,473 | 23.4% | EDGAR |
| SC 13G | 2021-02-08 | Israel Biotech Fund I, L.P. | Ayala Pharmaceuticals, Inc. | 3,315,119 | 25.9% | EDGAR |
| SC 13G | 2021-02-05 | Novartis Institutes for BioMedical Research, Inc. | Ayala Pharmaceuticals, Inc. | 698,777 | 5.5% | EDGAR |
| SC 13G | 2021-02-03 | WELLINGTON MANAGEMENT GROUP LLP | Ayala Pharmaceuticals, Inc. | 755,355 | 5.9% | EDGAR |
| SC 13G | 2020-05-15 | Harel Insurance Investments & Financial Services Ltd. | Ayala Pharmaceuticals, Inc. | 2,163,834 | 17.4% | EDGAR |